cyclophosphamide ( nsc-26271 ) maintenance therapy after a second remission of childhood acute lymphoblastic leukemia : comparative clinical trial ( standard dose versus intermittent high dose versus cyclophosphamide plus cytosine arabinoside ( nsc-63878 ) ) .
C0010583
cyclophosphamide
C0280520
cyclophosphamide